Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Inline UV Absorbance Monitoring – V 2.0

Posted on By


Biosimilars: SOP for Inline UV Absorbance Monitoring – V 2.0


Standard Operating Procedure for Inline UV Absorbance Monitoring in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/200/2025
Supersedes SOP/BS/200/2022
Page No. Page 1 of 9
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define a GMP-compliant procedure for operating, calibrating, and maintaining inline UV absorbance sensors used for monitoring biosimilar protein concentration during chromatography and ultrafiltration processes.

2. Scope

This SOP applies to all inline UV detectors integrated with chromatography skids, TFF systems, and UF/DF units within biosimilar downstream purification operations.

3. Responsibilities

  • Manufacturing: Operate and monitor inline UV systems during batch processing.
  • Engineering: Calibrate and maintain UV sensors as per schedule.
  • QA: Review UV absorbance data logs and deviations; verify calibration certificates.

4. Accountability

The Head of Manufacturing and Head of Engineering are accountable for ensuring the integrity and accuracy of inline UV absorbance monitoring systems.

5. Procedure

5.1 System Preparation and Verification

  1. Ensure the UV detector is powered and connected to the skid HMI or SCADA interface.
  2. Check that the correct wavelength (typically 280 nm for protein detection) is selected.
  3. Verify that the system baseline is stable before starting the purification run.

5.2 Calibration and Standardization

  1. Perform calibration using potassium dichromate standards at specified concentrations (Annexure-1).
  2. Record absorbance values at 280 nm and validate linearity across the range (e.g., 0.1 to 2.0 AU).
  3. Calibrate annually or as per manufacturer recommendation.
  4. Document all calibration activity in Annexure-2.

5.3 Inline Monitoring During Operation

  1. During chromatography or filtration, monitor the UV signal continuously.
  2. Use UV trace to identify:
    • Peak elution windows
    • Breakthrough detection
    • End-of-run indication
  3. Capture data in real-time using integrated data acquisition systems.
  4. Compare peak profiles with batch standards to detect anomalies.

5.4 Signal Threshold and Trigger Points

  1. Set UV absorbance thresholds in skid automation (e.g., 0.1 AU for elution start, 0.05 AU for elution end).
  2. Ensure operator is trained on modifying or acknowledging UV-based triggers for fraction collection.
  3. Confirm fractionation valves respond to UV threshold accurately.

5.5 Data Logging and Batch Record Entry

  1. Ensure continuous UV data is logged in electronic batch record or SCADA system.
  2. Export absorbance curves for archiving and review.
  3. Log any deviation from expected UV pattern in Annexure-3.

5.6 Maintenance and Cleaning

  1. Flush UV flow cell with WFI post-batch.
  2. Use 0.1 M NaOH for weekly sanitization, followed by neutralization and rinse.
  3. Inspect quartz cell for fouling or damage every month and clean if needed.

5.7 Deviation Handling

  1. In case of signal loss, drift, or non-linearity:
    • Pause operation if required
    • Document incident (Annexure-3)
    • Switch to offline UV confirmation for critical process points

6. Abbreviations

  • AU: Absorbance Unit
  • UV: Ultraviolet
  • SCADA: Supervisory Control and Data Acquisition
  • WFI: Water for Injection

7. Documents

  1. UV Calibration Standards Log – Annexure-1
  2. UV Calibration Record – Annexure-2
  3. UV Deviation Log – Annexure-3

8. References

  • ICH Q8 – Pharmaceutical Development
  • PDA TR 13 – Fundamentals of UV Monitoring in Biotech Processing
  • FDA Guidance on PAT (Process Analytical Technology)

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: UV Calibration Standards Log

Date Standard Concentration (mg/mL) Theoretical AU Observed AU
04/05/2025 Potassium Dichromate 0.2 0.400 0.398

Annexure-2: UV Calibration Record

Date Instrument ID Wavelength Status Calibrated By
04/05/2025 UV-280X 280 nm Pass Ajay Verma

Annexure-3: UV Deviation Log

Date Batch No. Deviation Impact Action Taken
03/05/2025 BS-PUR-116 Signal Drop Mid-Run Minor Switched to offline UV check

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Updated calibration frequency and deviation logging format Audit compliance
See also  Biosimilars: SOP for Cleaning and Sanitization of Bioreactors - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Real-Time SOP Compliance Monitoring Using QMS Tools
Next Post: Sterile Injection Manufacturing: SOP for Documentation of Packaging Line Performance – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version